COMMUNIQUÉS West-GlobeNewswire

-
SCYNEXIS to Participate in Guggenheim’s 6th Annual Biotechnology Conference
30/01/2024 -
Roivant to Report Financial Results for the Third Quarter Ended December 31, 2023, and Provide Business Update on Tuesday, February 13, 2024
30/01/2024 -
Exagen Inc. to Participate in the 2024 BTIG MedTech, Digital Health, Life Science & Diagnostic Tools Conference
30/01/2024 -
Vaxcyte Announces Commencement of Proposed Public Offering of Common Stock and Pre-Funded Warrants
30/01/2024 -
Autonomix Medical, Inc. Completes $8,000,000 Transaction for Exclusive Worldwide Rights to Technology for Cardiology Field Use – Over 100 patents in portfolio
30/01/2024 -
EverythingALS Releases First Open Data From the Austen Speech Study
30/01/2024 -
Eurobio Scientific: FISCAL YEAR 2023, STRATEGIC TRANSFORMATION OF THE GROUP
30/01/2024 -
Eurobio Scientific : EXERCICE 2023, CONFIRMATION DE LA TRANSFORMATION STRATEGIQUE
30/01/2024 -
Defender Pharmaceuticals Receives Complete Response Letter from the U.S. Food and Drug Administration for its Intranasal Scopolamine (DPI-386) New Drug Application for the Prevention of Nausea and Vomiting Induced by Motion in Adults
30/01/2024 -
Novo Nordisk A/S - share repurchase programme
30/01/2024 -
Kairos Pharma Doses First Patient in Phase 2 Trial of Lead Drug Candidate ENV105 with Apalutamide to Improve Therapy Sensitivity for Castrate-Resistant Prostate Cancer
30/01/2024 -
Palisade Bio Announces Exercise of Previously Issued Warrants for $2.5 Million
30/01/2024 -
FDA Clears Magstim Transcranial Magnetic Stimulation System Horizon 3.0 with StimGuide Pro
30/01/2024 -
Cyclacel Pharmaceuticals Announces the Appointment of Brian Schwartz, M.D. as Chief Medical Officer
30/01/2024 -
Generation Lab Emerges from Stealth with Funding Round and Mission to Extend the Human Healthspan – Waitlist for Its Clinically Driven At-Home Aging Test + Personalized Aging Intervention Opens Today
30/01/2024 -
Autonomix Medical, Inc. Completes Transaction for Exclusive Worldwide Rights to Technology for Cardiology Field Use
30/01/2024 -
NMDP BioTherapies Appoints New President to Lead Next Phase in Life-Saving Therapy Development
30/01/2024 -
60 Degrees Pharmaceuticals Announces Pricing of $2.4 Million Public Offering
30/01/2024 -
Aeroflow Health Announces New Leadership Appointments Amid Company Growth
30/01/2024
Pages